Esflurbiprofen

艾司氟比洛芬

Report date: 2025/04/28 22:35:30

Base Information

Drug NameEsflurbiprofen
Drug Alias Name艾氟洛芬esflurbiprofenoesflurbiprofenumLOQOA Tape, SFlurbiprofen, Sflurbiprofen transdermalS-Flurbiprofen +[11
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1
Therapy Area/IndicationsInflammationOsteoarthritis, KneeOsteoarthritis +[4
Global Approved IndicationsInflammationOsteoarthritis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2015/09/28
Country/TerritoryGermanyIndonesiaMainland China +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
China Registration ClassN/A

Develop Information

Active IndicationsInflammationOsteoarthritis, KneeOsteoarthritis
Inactive IndicationsArthralgia

Other Information

ATC CodeM02AA29
Related LinksDrugBankKEGG